NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.

Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.

U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

PUBLICATIONS

Mass Spectrometry Advances and Perspectives for the Characterization of Emerging Adoptive Cell Therapies

Published

Author(s)

Camille O. Lombard-Banek, John E. Schiel

Abstract

Adoptive cell therapy is an emerging anti-cancer modality, whereby the patient’s own immune cells are engineered to express T-cell receptor (TCR) or chimeric antigen receptor (CAR). CAR-T cell therapies have advanced the furthest, with recent approvals of two treatments by the Food and Drug Administration of Kymriah (trisagenlecleucel) and Yescarta (axicabtagene ciloleucel). Recent developments in proteomic analysis by mass spectrometry (MS) make this technology uniquely suited to enable the comprehensive identification and quantification of the relevant biochemical architecture of CAR-T cell therapies and fulfill current unmet needs for CAR-T product knowledge. These advances include improved sample preparation methods, enhanced separation technologies, and extension of MS-based proteomic to single cells. Innovative technologies such as proteomic analysis of raw material quality attributes (MQA) and final product quality attributes (PQA) may provide insights that could ultimately fuel development strategies and lead to broad implementation.
Citation
Molecules
Pub Type
Journals

Download Paper

Local Download

Keywords

Proteomics, CAR-T, biopharmaceutical, mass spectrometry
Proteomics, Chemistry, Bioscience, Biomanufacturing and Analytical chemistry

Citation

Lombard-Banek, C. and Schiel, J. (2020), Mass Spectrometry Advances and Perspectives for the Characterization of Emerging Adoptive Cell Therapies, Molecules, [online], https://tsapps.nist.gov/publication/get_pdf.cfm?pub_id=929609 (Accessed October 16, 2025)

Issues

If you have any questions about this publication or are having problems accessing it, please contact [email protected].

Created March 19, 2020, Updated April 28, 2020
Was this page helpful?